Biosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicineRare DiseasesDermatologyMusculoskeletal DisordersGastroenterologyRheumatology
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trialMarch 29, 2023DermatologyMixed TopicsAdolescent Medicine
Topical delgocitinib shows promise for chronic hand eczema, pivotal trial showsMarch 27, 2023Dermatology
FDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023GastroenterologyDermatologyRheumatology
Anifrolumab shows promise in refractory discoid lupus erythematosusMarch 27, 2023DermatologyRheumatology
Pilot study evaluates sensitive skin burden in persons of colorMarch 23, 2023Diversity in MedicineDermatology
Expert shares her tips for diagnosing, treating onychomycosisMarch 23, 2023Infectious DiseasesDermatology
Cases of potentially deadly fungus jump 200%: CDCMarch 22, 2023Mixed TopicsInfectious DiseasesDermatology
Phase 3 prurigo nodularis trial shows positive results for nemolizumabMarch 22, 2023DermatologyRare Diseases
Novel therapy shows promise for treating skin-predominant dermatomyositisMarch 21, 2023DermatologyRheumatology
